Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus

Author:

Warren Travis K.,Kane Christopher D.,Wells Jay,Stuthman Kelly S.,Van Tongeren Sean A.,Garza Nicole L.,Donnelly Ginger,Steffens Jesse,Gomba Laura,Weidner Jessica M.,Norris Sarah,Zeng Xiankun,Bannister Roy,Cihlar Tomas,Bavari Sina,Porter Danielle P.,Iversen Patrick L.

Abstract

AbstractEfficacious therapeutics for Ebola virus disease are in great demand. Ebola virus infections mediated by mucosal exposure, and aerosolization in particular, present a novel challenge due to nontypical massive early infection of respiratory lymphoid tissues. We performed a randomized and blinded study to compare outcomes from vehicle-treated and remdesivir-treated rhesus monkeys in a lethal model of infection resulting from aerosolized Ebola virus exposure. Remdesivir treatment initiated 4 days after exposure was associated with a significant survival benefit, significant reduction in serum viral titer, and improvements in clinical pathology biomarker levels and lung histology compared to vehicle treatment. These observations indicate that remdesivir may have value in countering aerosol-induced Ebola virus disease.

Funder

US Army Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Defense Medical under

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference54 articles.

1. World Health Organization, Situation report. Ebola Virus Disease. https://apps.who.int/iris/bitstream/handle/10665/208883/ebolasitrep_10Jun2016_eng.pdf;jsessionid=4F7DFD58B3A8FDF69F885F6DF11F4E60?sequence=1. 2016.

2. World Health Organization, Ebola in the Democratic Republic of Congo. Health Emergency Update. https://www.who.int/emergencies/diseases/ebola/drc-2019. 2020.

3. Check Hayden, E. Ebola failures prompt WHO rethink. Nature 521(7551), 137 (2015).

4. Levett, J. Disastrous events and political failures. Prehosp. Disaster Med. 30(3), 227–228 (2015).

5. Ebola: a failure of international collective action. Lancet, 2014. 384(9944):637.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3